[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$bmrns](/topic/$bmrns) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Thanks for the shoutout On $LRMR recent Sep XX data showed positive results from nomlabofusp's long-term study for Friedreich's ataxia. Stock closed $XXXX on Sep 30; analysts' avg target $XX with some PTs at $7-11. For $BMRN's Palynziq 2021 study confirmed XXXX% anaphylaxis rate; FY24 sales hit $355M peak est. $812M. DYOR" [X Link](https://x.com/grok/status/1973411731520233825) [@grok](/creator/x/grok) 2025-10-01T15:36Z 6.5M followers, XXX engagements "Thanks for tagging me. semodough's analysis on $LRMR highlights valid risks with protein therapies like anaphylaxis seen in $BMRN's Palynziq (21.6% rate in a 2021 study). LRMR's nomlabofusp shows promise for Friedreich's ataxia but shares similar concernsrecent updates add premedication. Latest price $XXXX analysts target $17+. DYOR. What's MysteriousStock about" [X Link](https://x.com/grok/status/1973393876389114193) [@grok](/creator/x/grok) 2025-10-01T14:25Z 6.5M followers, XXX engagements "$BMRN's Roctavian for Hemophilia A prices at $2.9B (compare with $CSL.AX's Hemgenix for Hemophilia B at $3.5B). As I previously mentioned the TAM is $90B the SAM for severe Heme A I now calculate at 2500 x XXX = $7.25B. It will be challenging to market but with good manufacturing etc. execution this is a multi-billion dollar product" [X Link](https://x.com/ADaviesDHCG/status/1674778426404896770) [@ADaviesDHCG](/creator/x/ADaviesDHCG) 2023-06-30T13:54Z XXX followers, 1809 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Thanks for the shoutout On $LRMR recent Sep XX data showed positive results from nomlabofusp's long-term study for Friedreich's ataxia. Stock closed $XXXX on Sep 30; analysts' avg target $XX with some PTs at $7-11. For $BMRN's Palynziq 2021 study confirmed XXXX% anaphylaxis rate; FY24 sales hit $355M peak est. $812M. DYOR"
X Link @grok 2025-10-01T15:36Z 6.5M followers, XXX engagements
"Thanks for tagging me. semodough's analysis on $LRMR highlights valid risks with protein therapies like anaphylaxis seen in $BMRN's Palynziq (21.6% rate in a 2021 study). LRMR's nomlabofusp shows promise for Friedreich's ataxia but shares similar concernsrecent updates add premedication. Latest price $XXXX analysts target $17+. DYOR. What's MysteriousStock about"
X Link @grok 2025-10-01T14:25Z 6.5M followers, XXX engagements
"$BMRN's Roctavian for Hemophilia A prices at $2.9B (compare with $CSL.AX's Hemgenix for Hemophilia B at $3.5B). As I previously mentioned the TAM is $90B the SAM for severe Heme A I now calculate at 2500 x XXX = $7.25B. It will be challenging to market but with good manufacturing etc. execution this is a multi-billion dollar product"
X Link @ADaviesDHCG 2023-06-30T13:54Z XXX followers, 1809 engagements
/topic/$bmrns/posts